Company Profile
AN2 Therapeutics Stock Price, News & Analysis
- Ticker:
- ANTX
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- United States
Stock performance
4.50 USD (-7.02%)
Close
Last updated: July 10, 2026 at 00:00
162.07M USD
Market cap
Why the stock is moving
ANTX is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
AN2 Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, AN2 Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
AN2 Therapeutics follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, AN2 Therapeutics sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
Zimmer Biomet Names Chintan Desai President of Asia Pacific Region
ZBH · Source: Zimmer Biomet
- 02
Spero Therapeutics Announces $105 Million Non-Recourse Non-Dilutive Financing Backed by a Portion of Utebzi Milestones & Royalties
SPRO · Source: Spero Therapeutics
- 03
- 04
Enlivex Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Allocetra™ in Age-Related Knee Osteoarthritis
ENLV · Source: Enlivex Therapeutics
- 05
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results
ZBH · Source: Zimmer Biomet
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of AN2 Therapeutics (ANTX)?
AN2 Therapeutics (ANTX) most recently closed at 4.50 USD, a -7.02% move versus the previous session.
What is the market cap of AN2 Therapeutics (ANTX)?
AN2 Therapeutics currently has a market capitalization of 162.07M USD on BioPharmSignal.
What does AN2 Therapeutics do?
AN2 Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is ANTX stock listed?
AN2 Therapeutics (ANTX) is associated with NASDAQ, United States, Biotechnology.
What is Therapeutics?
AN2 Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is AN2 Therapeutics targeting with Therapeutics?
AN2 Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.